Design Therapeutics, Inc. (DSGN)
Largest Insider Buys in Sector
DSGN Stock Price History Chart
DSGN Stock Performance
About Design Therapeutics, Inc.
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive …
Insider Activity of Design Therapeutics, Inc.
Over the last 12 months, insiders at Design Therapeutics, Inc. have bought $104,604 and sold $3.46M worth of Design Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Design Therapeutics, Inc. have bought $15.55M and sold $1.87M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Schmid John P. (director) — $199,477. Berger Heather A. (director) — $4,866.
The last purchase of 17,809 shares for transaction amount of $66,606 was made by Schmid John P. (director) on 2024‑03‑25.
List of Insider Buy and Sell Transactions, Design Therapeutics, Inc.
| 2024-08-09 | Sale | director | 814,874 1.4426% | $4.25 | $3.46M | +21.46% | ||
| 2024-03-25 | director | 17,809 0.0318% | $3.74 | $66,606 | +17.51% | |||
| 2024-03-25 | director | 1,300 0.0023% | $3.74 | $4,866 | +17.51% | |||
| 2024-03-22 | director | 9,156 0.0156% | $3.62 | $33,133 | +14.62% | |||
| 2023-09-29 | director | 21,000 0.0373% | $2.35 | $49,287 | +21.61% | |||
| 2023-08-29 | director | 1.96M 3.6838% | $2.44 | $4.78M | +15.58% | |||
| 2023-08-29 | director | 12,000 0.0213% | $2.31 | $27,670 | +15.58% | |||
| 2023-08-28 | director | 275,000 0.48% | $2.15 | $591,250 | +21.14% | |||
| 2022-12-20 | director | 40,000 0.0725% | $8.14 | $325,432 | -27.73% | |||
| 2022-12-20 | director | 40,000 0.0725% | $8.14 | $325,432 | -27.73% | |||
| 2022-12-20 | President and CEO | 6,300 0.0118% | $8.38 | $52,763 | -27.73% | |||
| 2022-12-19 | director | 360,000 0.6698% | $8.63 | $3.11M | -29.65% | |||
| 2022-12-19 | director | 360,000 0.6698% | $8.63 | $3.11M | -29.65% | |||
| 2022-12-19 | President and CEO | 1,150 0.0021% | $8.47 | $9,741 | -29.65% | |||
| 2022-12-16 | director | 500,000 0.8485% | $8.28 | $4.14M | -32.42% | |||
| 2022-12-16 | director | 500,000 0.8485% | $8.28 | $4.14M | -32.42% | |||
| 2022-12-09 | director | 15,000 0.0273% | $7.96 | $119,426 | -22.01% | |||
| 2022-03-21 | 25,000 0.0461% | $18.99 | $474,680 | -22.95% | ||||
| 2022-03-18 | Sale | 13,200 0.0246% | $20.34 | $268,488 | -26.91% | |||
| 2021-08-31 | director | 40,000 0.0713% | $15.45 | $618,000 | +0.60% |
Insider Historical Profitability
| Schmid John P. | director | 26965 0.0476% | $5.93 | 2 | 0 | |
| Berger Heather A. | director | 1300 0.0023% | $5.93 | 1 | 0 | |
| William Arsani | director | 0 0% | $5.93 | 5 | 1 | <0.0001% |
| George Simeon | director | 6526476 11.5267% | $5.93 | 4 | 0 | <0.0001% |
| SR One Capital Fund I Aggregator LP | director | 6526476 11.5267% | $5.93 | 4 | 0 | <0.0001% |
Institutional Investor Ownership
| Sr One Capital Management Lp | $26.3M | 11.55 | 6.53M | 0% | +$0 | 7.22 | |
| Logos Global Management Lp | $20.28M | 8.91 | 5.03M | 0% | +$0 | 2.19 | |
| BlackRock | $9.16M | 4.03 | 2.27M | -4.46% | -$427,385.50 | <0.0001 | |
| Baker Bros Advisors LP | $6.7M | 2.94 | 1.66M | +10.81% | +$653,343.64 | 0.05 | |
| Tang Capital Management, LLC | $5.97M | 2.62 | 1.48M | +0.02% | +$1,209.00 | 0.02 |